271 related articles for article (PubMed ID: 31727160)
21. Transient receptor potential melastatin 3 dysfunction in post COVID-19 condition and myalgic encephalomyelitis/chronic fatigue syndrome patients.
Sasso EM; Muraki K; Eaton-Fitch N; Smith P; Lesslar OL; Deed G; Marshall-Gradisnik S
Mol Med; 2022 Aug; 28(1):98. PubMed ID: 35986236
[TBL] [Abstract][Full Text] [Related]
22. Cellular Immune Function in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).
Cliff JM; King EC; Lee JS; Sepúlveda N; Wolf AS; Kingdon C; Bowman E; Dockrell HM; Nacul L; Lacerda E; Riley EM
Front Immunol; 2019; 10():796. PubMed ID: 31057538
[TBL] [Abstract][Full Text] [Related]
23. A systematic review of enteric dysbiosis in chronic fatigue syndrome/myalgic encephalomyelitis.
Du Preez S; Corbitt M; Cabanas H; Eaton N; Staines D; Marshall-Gradisnik S
Syst Rev; 2018 Dec; 7(1):241. PubMed ID: 30572962
[TBL] [Abstract][Full Text] [Related]
24. Potential Therapeutic Benefit of Low Dose Naltrexone in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Role of Transient Receptor Potential Melastatin 3 Ion Channels in Pathophysiology and Treatment.
Cabanas H; Muraki K; Eaton-Fitch N; Staines DR; Marshall-Gradisnik S
Front Immunol; 2021; 12():687806. PubMed ID: 34326841
[TBL] [Abstract][Full Text] [Related]
25. A systematic review of mitochondrial abnormalities in myalgic encephalomyelitis/chronic fatigue syndrome/systemic exertion intolerance disease.
Holden S; Maksoud R; Eaton-Fitch N; Cabanas H; Staines D; Marshall-Gradisnik S
J Transl Med; 2020 Jul; 18(1):290. PubMed ID: 32727475
[TBL] [Abstract][Full Text] [Related]
26. MicroRNAs hsa-miR-99b, hsa-miR-330, hsa-miR-126 and hsa-miR-30c: Potential Diagnostic Biomarkers in Natural Killer (NK) Cells of Patients with Chronic Fatigue Syndrome (CFS)/ Myalgic Encephalomyelitis (ME).
Petty RD; McCarthy NE; Le Dieu R; Kerr JR
PLoS One; 2016; 11(3):e0150904. PubMed ID: 26967895
[TBL] [Abstract][Full Text] [Related]
27. A systematic review and meta-analysis of urinary biomarkers in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).
Taccori A; Maksoud R; Eaton-Fitch N; Patel M; Marshall-Gradisnik S
J Transl Med; 2023 Jul; 21(1):440. PubMed ID: 37408028
[TBL] [Abstract][Full Text] [Related]
28. Novel identification and characterisation of Transient receptor potential melastatin 3 ion channels on Natural Killer cells and B lymphocytes: effects on cell signalling in Chronic fatigue syndrome/Myalgic encephalomyelitis patients.
Nguyen T; Staines D; Nilius B; Smith P; Marshall-Gradisnik S
Biol Res; 2016 May; 49(1):27. PubMed ID: 27245705
[TBL] [Abstract][Full Text] [Related]
29. Characterization of IL-2 Stimulation and TRPM7 Pharmacomodulation in NK Cell Cytotoxicity and Channel Co-Localization with PIP
Du Preez S; Eaton-Fitch N; Cabanas H; Staines D; Marshall-Gradisnik S
Int J Environ Res Public Health; 2021 Nov; 18(22):. PubMed ID: 34831634
[TBL] [Abstract][Full Text] [Related]
30. Intermittent and graded exercise effects on NK cell degranulation markers LAMP-1/LAMP-2 and CD8
Broadbent S; Coutts R
Physiol Rep; 2017 Mar; 5(5):. PubMed ID: 28275109
[TBL] [Abstract][Full Text] [Related]
31. Surveying the Metabolic and Dysfunctional Profiles of T Cells and NK Cells in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
Maya J
Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569313
[TBL] [Abstract][Full Text] [Related]
32. A Systematic Review of Probiotic Interventions for Gastrointestinal Symptoms and Irritable Bowel Syndrome in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME).
Corbitt M; Campagnolo N; Staines D; Marshall-Gradisnik S
Probiotics Antimicrob Proteins; 2018 Sep; 10(3):466-477. PubMed ID: 29464501
[TBL] [Abstract][Full Text] [Related]
33. Role of adaptive and innate immune cells in chronic fatigue syndrome/myalgic encephalomyelitis.
Brenu EW; Huth TK; Hardcastle SL; Fuller K; Kaur M; Johnston S; Ramos SB; Staines DR; Marshall-Gradisnik SM
Int Immunol; 2014 Apr; 26(4):233-42. PubMed ID: 24343819
[TBL] [Abstract][Full Text] [Related]
34. Unperturbed Cytotoxic Lymphocyte Phenotype and Function in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients.
Theorell J; Bileviciute-Ljungar I; Tesi B; Schlums H; Johnsgaard MS; Asadi-Azarbaijani B; Bolle Strand E; Bryceson YT
Front Immunol; 2017; 8():723. PubMed ID: 28694809
[TBL] [Abstract][Full Text] [Related]
35. A systematic review of neurological impairments in myalgic encephalomyelitis/ chronic fatigue syndrome using neuroimaging techniques.
Maksoud R; du Preez S; Eaton-Fitch N; Thapaliya K; Barnden L; Cabanas H; Staines D; Marshall-Gradisnik S
PLoS One; 2020; 15(4):e0232475. PubMed ID: 32353033
[TBL] [Abstract][Full Text] [Related]
36. Longitudinal analysis of immune abnormalities in varying severities of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients.
Hardcastle SL; Brenu EW; Johnston S; Nguyen T; Huth T; Ramos S; Staines D; Marshall-Gradisnik S
J Transl Med; 2015 Sep; 13():299. PubMed ID: 26370228
[TBL] [Abstract][Full Text] [Related]
37. Cytotoxic lymphocyte microRNAs as prospective biomarkers for Chronic Fatigue Syndrome/Myalgic Encephalomyelitis.
Brenu EW; Ashton KJ; van Driel M; Staines DR; Peterson D; Atkinson GM; Marshall-Gradisnik SM
J Affect Disord; 2012 Dec; 141(2-3):261-9. PubMed ID: 22572093
[TBL] [Abstract][Full Text] [Related]
38. Investigation into the restoration of TRPM3 ion channel activity in post-COVID-19 condition: a potential pharmacotherapeutic target.
Sasso EM; Muraki K; Eaton-Fitch N; Smith P; Jeremijenko A; Griffin P; Marshall-Gradisnik S
Front Immunol; 2024; 15():1264702. PubMed ID: 38765011
[TBL] [Abstract][Full Text] [Related]
39. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome - Evidence for an autoimmune disease.
Sotzny F; Blanco J; Capelli E; Castro-Marrero J; Steiner S; Murovska M; Scheibenbogen C;
Autoimmun Rev; 2018 Jun; 17(6):601-609. PubMed ID: 29635081
[TBL] [Abstract][Full Text] [Related]
40. Impact of Long-Term Cryopreservation on Blood Immune Cell Markers in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Implications for Biomarker Discovery.
Gómez-Mora E; Carrillo J; Urrea V; Rigau J; Alegre J; Cabrera C; Oltra E; Castro-Marrero J; Blanco J
Front Immunol; 2020; 11():582330. PubMed ID: 33329554
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]